Provides drug monographs of individual drugs, drug interactions, drug identifier, black box warnings, bioequivilency codes, orphan drugs, medication watches, etc.
Demystifying Opioid Conversion Calculations by Mary Lynn McPhersonPraised by students and instructors for its engaging approach to teaching a very complex subject, Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing, has long been the go-to guide for learning how to calculate opioid conversions. Now in its second edition, this reference is a must-have for clinicians involved in pain management at all levels. Written by pain management expert Mary Lynn McPherson, PharmD, Demystifying Opioid Conversion Calculations focuses on the calculations that practitioners use in actual practice, providing realistic scenarios for decision making. The revised edition covers the entire spectrum of opioid analgesics used to manage patients with moderate to severe pain and serious life¬limiting illnesses. Inside this updated and expanded guide you'll find: Learning objectives and practice problems with solutions in each chapter New clinical cases throughout, including a baker's dozen of opioid conversion MIScalculation cases with detailed explanations Expanded information on less commonly used opioids, including levorphanol and nalbuphine Important summary points at the end of each chapter Updated pearls, pitfalls, and fast facts Demystifying Opioid Conversion Calculations is designed to help practitioners including pharmacists, physicians, nurses and others develop a high level of skill in performing the required mathematical calculations associated with opioid conversions, plus the confidence to safely and effectively manage their patients' needs for pain relief.
ISBN: 1585284297
Publication Date: 2018-09-30
Renal Pharmacotherapy by Larry K. Golightly; Isaac Teitelbaum; Bonita A. Simendinger, PharmD, BCPS; Tyree H. Kiser, PharmD, BCPS; Gerard R. Barber, RPh, MPH; Nancy M. Stolpman, PharmD,To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications. This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types. Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.